Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
2-HOBA: Multiple Dosing Study in Older Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 14, 2018
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
2-HOBA: Multiple Dosing Study in Healthy Humans
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 13, 2018
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Brain Penetrance of 2-HOBA in Humans
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 12, 2018
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
2-HOBA: Initial Evaluation in Humans
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 06, 2017
Lead Product(s) : 2-hydroxybenzylamine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Vanderbilt University | National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HMB
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : University of Central Florida
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 05, 2016
Lead Product(s) : HMB
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : University of Central Florida
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HMB
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Iowa State University
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 23, 2016
Lead Product(s) : HMB
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Iowa State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HMB
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Undisclosed
Sponsor : Iowa State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of HMB Supplementation on Recovery Following ACL Surgery
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
November 11, 2015
Lead Product(s) : HMB
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Undisclosed
Sponsor : Iowa State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HMB-FA
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Koach Sport and Nutrition
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of 14-days of HMB-free Acid on Changes in Muscle During 4-days of Survival Training
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
July 20, 2015
Lead Product(s) : HMB-FA
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Koach Sport and Nutrition
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adenosine Triphosphate
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : University of Tampa
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 21, 2014
Lead Product(s) : Adenosine Triphosphate
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : University of Tampa
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HMB
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Sponsor : Iowa State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
January 23, 2014
Lead Product(s) : HMB
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Sponsor : Iowa State University
Deal Size : Inapplicable
Deal Type : Inapplicable